Ticker Details
Keros Therapeutics, Inc.
IPO Date:	April 8, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$218.69M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.11 | 2.80%
Avg Daily Range (30 D):	$0.32 | 3.00%
Avg Daily Range (90 D):	$0.29 | 2.65%

Institutional Daily Volume
Avg Daily Volume:	.29M
Avg Daily Volume (30 D):	.16M
Avg Daily Volume (90 D):	.21M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	2,150
Avg Institutional Trade:	$1.87M
Avg Institutional Trade (30 D):	$.58M
Avg Institutional Trade (90 D):	$1.04M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.9M
Avg Closing Trade (30 D):	$.58M
Avg Closing Trade (90 D):	$1.08M
Avg Closing Volume:	61.79K

News

May 26, 2026 @ 5:00 PM Duchenne Muscular Dystrophy Clinical Trial Pipelin... Source: Delveinsight

Mar 9, 2026 @ 12:00 PM Keros Therapeutics Presents Additional Clinical Da... Source: Na

Nov 20, 2025 @ 9:01 PM Keros Therapeutics Announces Final Results of Tend... Source: Globe Newswire

Nov 19, 2025 @ 11:00 AM Keros Therapeutics Announces Preliminary Results o... Source: Keros Therapeutics, Inc.

Sep 23, 2025 @ 5:00 PM TGF-β Inhibitors Clinical Trial Pipeline Accele... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.22	$-1.45	$-1.21
Diluted EPS	$-3.22	$-1.45	$-1.21
Revenue	$14.54M	$M	$.03M
Gross Profit
Net Income / Loss	$-83.16M	$-28.71M	$-23.71M
Operating Income / Loss	$-101.47M	$-30.94M	$-25.88M
Cost of Revenue
Net Cash Flow	$-432.61M	$-23.89M	$-5.92M
PE Ratio